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1. Introduction 
Renal transplantation has become the treatment of choice for end-stage renal disease due to 
advances in surgical techniques, perioperative management, and immunosuppressive 
regimens. Surgical techniques for kidney transplantation were first described in 1951 by 
Kuss et al. and have since changed very little. The most common surgical procedure is 
extraperitoneal transplantation in the right iliac fossa, with end-to-side to the external iliac 
artery or end-to-end anastomosis to the internal iliac artery, and end-to-side anastomosis to 
the external iliac vein. 
The overall incidence of vascular complications following kidney transplantation is low, 
especially when compared to other solid organ transplantation of such organs as the liver or 
pancreas. The incidence of vascular complications following renal transplantation ranges 
from 3% to 15%.1 Arterial complications occur more frequently and are more dangerous 
than venous. Both arterial and venous thromboses tend to occur within the first few days of 
transplantation. Improvements in immunosuppressive therapy have led to a 1-year post 
transplantation acute rejection incidence rate of <20%. The incidence of graft loss due to 
acute and chronic rejection is decreasing; however, the incidence of early allograft loss due 
to acute vascular complications has remained constant, accounting for a proportionally 
higher percentage of early loss. Reducing the incidence of vascular complications depends 
to a great extent on the careful evaluation of the recipient, the donor kidney, and the 
surgical technique used for implantation. 
1.1 Transplantation region 
As a general rule, left kidney is implanted in the right iliac fossa, whereas right kidney is 
implanted in the left iliac fossa. Using this technique the urinary collecting system is 
medially located, facilitating easy access to the ureter and possible percutaneous kidney 
biopsy; however, because left donor nephrectomy is commonly performed and the right 
iliac veins are more superficial, kidneys are implanted in the right retroperitoneal iliac fossa. 
The left iliac fossa is reserved primarily for pancreas transplantation candidates, patients 
with previous transplants, and those with vascular problems. In patients undergoing 
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simultaneous pancreas and renal transplantation, or in those with a history of surgery in 
both iliac regions intraperitoneal transplantation should be performed.  
1.2 Which kidney to choose – left or right? 
Right and left kidney transplant outcomes are similar;2 however, given a choice surgeons 
prefer the left kidney because the left renal vein is longer and less fragile, and anastomosis 
to the recipient right external iliac vein, which is situated superficial, is easier. Right kidney 
transplantation leads to more stretching of the anastomosis site because the right renal vein 
is short. On the other hand, a long renal artery may lead to a kink. In transplantation of 
kidneys with multiple renal arteries the contralateral kidney should be used because the 
duration of surgery is long, and hot and cold ischemia negatively affect graft survival.   
1.3 Preparation of the allograft 
Donor kidneys should be prepared on the back table before implantation in the recipient, 
whether obtained from a deceased or a living donor. Arterial anomalies, atheromatous 
plaques, thromboses, and intimal flaps that may be overlooked during explantation or 
donor nephrectomy. In such cases the duration of hot or cold ischemia will be kept to a 
minimum due to preparation performed on the back table.   
In living donor transplantation accessory superior pole or inferior pole arteries that may 
have escaped detection during back table preparation may become evident with cold 
perfusion; however; in transplants performed with deceased organs prepared with in situ 
perfusion, accessory arteries may be overlooked. The tissue surrounding the donor renal 
artery and vein should be mobilized without extreme dissection. Hemostasis should be 
maintained using cauterization to separate the perirenal fat tissue and tying or clipping the 
small venous structures, which will decrease the volume of bleeding during reperfusion.   
In deceased kidney transplantation the second flushing at the back table after explantation 
helps clean away remnant venous blood and facilitates detection of veins that may have 
been previously overlooked. Furthermore, flushing kidneys twice reduced the primary 
non-function rate.3 In donors with multiple arteries, 2 arteries should be unified as a 
single artery via trouser-like stenting, if possible (artery diameter >3 mm), and used as a 
single anastomosis in the recipient (Figure 1a). The smaller graft artery can be 
anastomosed end-to-side to the larger one (Figure 1b). Alternately, there can be 2 separate 
anastomoses performed on the internal iliac and external iliac arteries (Figure 1c).  
Superior pole arteries with a diameter <1 mm and an ischemic surface <1 cm2 can be ligated. 
Even if the surface appears pink with reperfusion following superior pole artery ligation, 
there will be a small ischemic area in deep region due to the nature of the renal artery 
system. As the inferior pole artery might also nourish the ureter, it is more difficult to 
sacrifice, and because of the area it nourishes there is the potential for ureterovesical 
anastomosis leakage, ureteral necrosis, and urinary fistula. The inferior pole artery should 
be anastomosed end-to-side to the renal artery, and in cases in which the iliac artery is 
extremely atherosclerotic it should be anastomosed to the inferior epigastric artery in an 
end-to-end fashion. 
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                                       (a)                                                                             (b) 
 
(c) 
Fig. 1. There are multipl alternatives in artery anastomosis. a. Anastomosis of donor renal 
arteries before transplantation. b. Donor accessory renal artery can be anastomosed to main 
renal artery. c. Two renal arteries can be anastomosed to the internal iliac artery and external 
iliac artery. 
1.4 Venous anastomosis 
In living donor transplantation if the donor does not have multiple renal arteries or 
collecting system anomalies the left kidney should be used, because the left renal vein is 
longer. In deceased renal transplantation choice of side is unimportant. The left kidney is 
preferred primarily because the right renal vein is shorter and the right renal vein wall is 
thinner than the left. Vein anastomosis should be performed prior to artery anastomosis. 
The most common technique is end-to-side anastomosis between the renal vein and external 
iliac vein (Figure 2); when this cannot be performed other techniques can be used. If the 
renal vein is short the internal iliac vein can be ligated to achieve mobility, followed by end-
to-side anastomosis to the external iliac vein. When the branches of the external iliac vein are 
occluded and the vena cava is functional, end-to-side anastomosis to the vena cava can be 
performed. When there is a short renal vein in cadaver transplants, venoplasty can be 
performed to extend the renal vein that is explanted along with vena cava. 
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After the iliac vein’s anastomosis site is determined a venous clamp is situated horizontally 
and venotomy is performed. To prevent stitching from the opposite wall 5/0 stitches are 
placed in all 4 quadrants of the iliac vein. It is stitched continuously with 5/0 non-
absorbable material. Another technique is situation of venous clamp horizontally. Venotomy 
is performed in accordance with the diameter of renal vein that will be anostomosed. 
Following the posterior wall, anterior wall anostomoses is performed with continue suture 
technique. In this tecnique, from outside to inside at distal corner of iliac venotomy and 
from inside to outside at distal corner of renal vein, folllowing posterior wall, anterior wall 
is erected continuously with the 6 / 0 polypropylene suture material. Surgeons must closely 
monitor the tension of the anastomosis and look for kinks (Figure 2).    
   
Fig. 2. End-to-side anastomosis of renal vein to the external iliac vein. 
1.5 Arterial anastomosis 
The renal arteries typically originate from the sides of the abdominal aorta, 1-2 cm distal of 
the superior mesenteric artery from the level of second lumbar vertebra. Normally, a single 
renal artery crosses the crura of the diaphragm and provides branches to the adrenal gland, 
kidneys, and ureters. Anatomical variation is more frequent than expected. Celiac truncus, 
superior mesenteric artery, phrenic artery, aortic bifurcation, common iliac artery, and even 
contralateral renal artery origin have been reported. Variations can be misleading during 
explantation and result in accidents during dissection. Renal arteries can be multiple (2-4 
arteries) and in cadaver explantation they should always be removed from the aorta with a 
patch. Multiple arteries tend to be bilateral. The right renal artery is located behind the vena 
cava and is longer than the left (right: 0.8-8.0 cm; left: 0.5-6 cm). Renal artery diameter differs 
in males and females and is approximately 6.4-7.8 mm.  
In 20% of cases the left kidney has multiple renal arteries.4 An accessory superior pole renal 
artery <1 mm can be fastened; however, for arteries with a diameter similar to the common 
renal artery anastomosis should be performed. When there a 2 renal arteries both can be 
anastomosed to the external iliac artery end-to-side, one can be anastomosed end-to-end to 
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the internal iliac artery and the other end-to-side to the external iliac artery, or the common 
renal artery can be anastomosed to the external iliac artery end-to-side and the inferior pole 
artery can be anastomosed to the inferior epigastric artery end-to-end. When the 
appropriate technique is used the vascular complication rate of multiple renal artery 
transplantation is similar to that of single renal artery transplantation.5  
In order to decrease postoperative lymphocele lymphatic channels surrounding the artery 
should be fastened and dissected as little as the anastomosis area. Arterial anastomosis is 
commonly performed in an end-to-side to the external iliac artery; however, in the right 
kidney, end-to-end anastomosis to the internal iliac artery can be performed. In such cases 
the contralateral internal iliac artery must not be fastened. Arterial dissection should be 
performed with vigilance because in marginal donors there could be arterial plaques.     
When dissection is completed the artery clamp should be positioned horizontally in a region 
without arterial plaques. Because the right kidney artery is long, it can be shortened to 
prevent formation of a kink. In left kidney transplantation anastomosis can be performed 
end-to-end to the internal iliac artery because the left renal artery is short. For large-
diameter arteries anastomosis should be performed in a continuous fashion with 6/0 non-
absorbable material and for small-diameter arteries it should be performed one-by-one with 
7/0 non-absorbable material (Figure 3). In a similar fashion, anastomosis is performed using 
an aortic patch in deceased transplants.  
 
Fig. 3. Anastomosis of renal artery end-to-side to the external iliac artery. 
1.6 Reperfusion  
The duration of arterial and venous anastomosis should not exceed 40 min. Anastomosis 
exceeding 40 min increases the risk of primary non-function. Before vascular clamps are 
opened it should be determined if there is air in the artery; when there is, heparinized 
solution should be injected. Additional clamps should be placed proximal to those that were 
www.intechopen.com
 
Vascular Surgery 
 
90
used during anastomosis and then the other clamps those used during anastomosis can be 
opened (Figure 4). The anastomosis region should be monitored for signs of bleeding. 
Bleeding usually results from a tributary vein or venous anastomosis line that is thinned 
due to extreme traction. If there is bleeding the site should be repaired using 5/0 or 6/0 non-
absorbable sutures. After hemostasis is achieved systemic blood pressure is increased, and 
then the artery clamps are opened, followed by the vein clamps. When all is as it should be 
the renal parenchyma becomes pink and urine outflow occurs within a matter of minutes. If  
this is not observed, possible causes should be reviewed. For example, in marginal donor or  
 
(a) 
 
(b) 
Fig. 4. a. Additional clamps can be placed proximal to the anastomosis. b. Before opening 
the clamps hemostasis must be cheched. 
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deceased transplants blotchy areas in the kidneys may be observed due to prolonged cold 
ischemia and the kidneys may not be totally perfused. Surgeons must first look for a kink in 
the renal artery and then for pulsation of the iliac artery proximal to the anastomosis line. If 
there is no obvious cause the artery should be clamped distally and injected with 
papaverine.  
After arterial and venous anastomosis, ureteral anastomosis is completed via 
ureteroneocystostomy or ureteroureterostomy. When the kidney is implanted in the iliac 
fossa, care should be taken to ascertain that the artery, vein, and ureter are correctly 
positioned and that there is no kink.  
2. Vascular thrombosis 
2.1 Renal vein thrombosis 
Renal vein thrombosis (RVT) is usually seen during the first post transplantation week in 
0.3%-6.1% of patients.6 Sudden oliguria, hematuria, pain in the transplantation region, life-
threatening rupture and bleeding are clinical signs of this complication. Risk factors include 
surgical technique, hypercoagulopathy, right kidney transplantation, kidney transplantation 
in the left iliac fossa, lymphoceles, and vascular compression due to hematoma or 
hypovolemia. Venous thrombosis due to a short renal vein is seen more frequently in right 
kidney transplants.7 In the late posttransplantation phase the risk factors are recurrent or de 
novo membranous nephropathy, iliofemoral vein thrombosis, thrombophilic disorders, and 
CMV infection.8,9 With ultrasonography (US) one can observe a swollen or hypoechoic graft, 
a ruptured area in the cortex, lack of renal venous or arterial flow, and reverse arterial 
diastolic flow. Even though these findings are consistent with RVT they can be seen in cases 
of vascular rejection and in such cases magnetic resonance (MR) angiography can be 
performed for differential diagnosis.   
The prognosis of RVT is poor. Acute thrombosis usually results in permanent graft loss. If RVT 
is suspected during the early postsurgical period additional surgery should be performed to 
save the graft. During such surgery the kidney should be extracted and reperfused, and 
should be re-implanted in the retroperitoneum after the iliac fossa is widened or implanted in 
the abdomen. Anastomosis should be proximal to the first anastomosis. In most center 
prophylactic low-dose subcutaneous heparin, sodium, or aspirin is used during the early 
postoperative period.10 Late-phase thromboses secondary to iliofemoral vein thrombosis, de 
novo membranous nephropathy, and thrombophilic disorders are extremely rare; 
percutaneous interventions are commonly used to treath such complications. 
2.2 Renal artery thrombosis 
2.2.1 Etiology 
Arterial thrombosis occurs in <1% of renal transplant patiens.11,12 The first sign of arterial 
thrombosis is a sudden decrease in urine outflow; physicians should be aware that in cases 
in which the native kidney is producing urine and there is a delay in graft function, this 
early sign could be masked. The most common causes of renal artery thrombosis are 
technical. During nephrectomy in living donors or cadavers an intimal flap in the renal 
artery, occlusion due to atherom plaque in the recipient internal iliac artery or renal artery 
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ostium, and torsion or kinking of the anastomosis can result in thrombosis. Other more rare 
causes include immunological reactions, hypercoagulopathy, cryoglobulin and anti-
phospholipid antibodies associated with hypercoagulopathy and observed in active lupus 
erythrematosus patients, and thrombogenic drugs such as cyclosporin and monoclonal 
antibody OKT-3.10,13     
2.2.2 Diagnosis 
In all patients prerenal and post-renal causes of thrombosis should be investigated before 
transplantation. Hypovolemia due to prerenal reasons or hypoperfusion resulting from 
congestive heart disease should be excluded. Obstruction should be excluded by inserting a 
foley catheter. Moreover, the vascular tree should be evaluated for thrombosis. Color 
Doppler US is a useful investigative tool that not only shows renal artery and vein flow, but 
also facilitates calculation of the intraparenchymal resistance index. Angiography, which is 
useful for evaluating renal artery stenosis, is seldom used for investigating thrombosis. 
Between the onset of arterial thrombosis and its diagnosis infarcts and necrosis can develop. 
Most cases eventually undergo nephrectomy as a result. Allograft loss due to thrombosis 
rarely occurs, but its consequences are serious.  
2.2.3 Treatment and prevention 
Treatment of thrombosis is urgent exploration of the renal artery. In most cases the time 
from diagnosis to surgery is so long that necrosis occurs and nephrectomy is required. 
During exploration if the anastomosis line and cortical perfusion are observed to be normal 
Doppler US investigation and intraoperative renal biopsy should be performed. Allograft 
loss due to thrombosis is rare, but serious. Epidemiologic research shows that thrombotic 
risk factors are divided into 2 groups: those that can be modified (dialysis, drugs, and 
surgery) and those that cannot be modified: (age, diabetes mellitus, and vascular anomalies). 
It was also reported that in the first postoperative month the risk of thrombosis is higher in 
patients that undergo preoperative peritoneal dialysis and retansplant.14  
Acetylsalicylic acid, low molecular weight heparin, and unfractionated heparin are used to 
prevent vascular thrombosis. It is reported that heparin, warfarin, and acetylsalicylic acid 
given in the early postoperative period decreases the vascular thrombosis rate, but increases 
the bleeding rate.15-17 These studies were retrospective case-control studies and the 
reliability, efficacy, and optimal utilization time of such agents that prevent allograft 
thrombosis as acetylsalicylic acid and heparin can only be ascertained by large, multicenter 
randomized studies.  
2.2.4 Prevention strategies  
1. The most common cause of thrombosis is surgical technique. Attention should be paid 
to the anastomosis technique and vascular dissection; in particular, the intimal layer 
must not be damaged.  
2. Acute tubular necrosis, one of the causes of vascular thrombosis, may be prevented by 
minimizing the duration of hot and cold ischemia.  
3. Early diagnosis of vascular or antibody-mediated rejection, and treatment reduces the 
risk of both endothelial and vascular thrombosis.  
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4. In patients with a high risk of thrombosis low molecular weight heparin, warfarin, or 
acetylsalicylic acid should be administered during the early postoperative period. 
3. Renal artery stenosis 
The most important vascular complication during the late postsurgical period is renal artery 
stenosis, which has an incidence rate of 2%-8%, but has also been reported to be as high as 
23%.18,19 Its signs are poor renal function test results, sudden onset of resistant hypertension, 
and life-threatening congestive heart failure.20 Most patients are investigated due to an 
initial diagnosis of rejection. Some patients with renal artery stenosis are asymptomatic. In 
asymptomatic renal transplant recipients renal artery stenosis is 12.4% based on routine 
Doppler screening, versus 2.4% in symptomatic patients.21 Renal artery stenosis occurs in 
the anastomosis region most frequently between post transplant month 3 and year 2, 
although it can be pre- or post-anastomosis in origin. The incidence of renal artery stenosis 
is higher in cases of end-to-end anastomosis.  
There are 3 types of renal artery stenosis: anastomotic, diffuse post-anastomotic, and 
widespread restriction in the distal arterial bed. The etiology of the anastomotic type is the 
restriction effect of the suture, and injury to donor vessels during nephrectomy. Intimal 
flaps in the vessel wall and subintimal dissection lead to intimal injury and hyperplasia. A 
kink in the artery or angulation when the kidney is being implanted leads to turbulent flow 
and stenosis in the anastomosis. The diffuse post-anastomotic type of stenosis can affect 
different regions of the artery (multiple stenosis), as well as the entire artery (diffuse 
stenosis). De novo (previously present) atherosclerosis in donor vessels can cause diffuse 
stenosis in the long term under the influence of immunosuppressive agents. The third type 
of stenosiswidespread stenosis in the distal arterial bedusually occurs due to immune-
mediated endothelial injury. Cytomegalovirus (CMV) leads to renal artery stenosis due to 
endothelial injury via proliferation in smooth muscle cells.  
Renal artery stenosis during the late post transplant period is most often seen in kidneys 
with multiple renal arteries. The stenosis rate (0%) for anastomoses performed via the aortic 
patch technique is much lower than that (5%) observed in anastomoses performed via 
techniques other than the patch.22 The aortic patch is specific to cadaveric transplantation.  
3.1 Diagnosis  
Doppler US, CT angiography, MR angiography, and angiographic imaging methods can be 
used to diagnose renal artery stenosis; however, angiography is the gold standard. Doppler 
US is routinely used to evaluate transplanted kidney parenchyma and vascular structures, 
and must be performed by experienced personel in order to achieve optimum results. In 
Doppler US, peak systolic velocity >2.5 m s–1 in the stenotic region is significant for renal 
artery stenosis. In a region close to the anastomosis site an iliac artery peak systolic velocity 
to renal artery velocity ratio >2 suggests stenosis.23 Patients suspected to have stenosis based 
on Doppler US should be evaluated with CT angiography, which provides valuable 
information about the location and extent of renal artery stenosis. Before CT angiography 
adequate hidration and N-acetylcysteine should be given in order to prevent contrast-
induced nephropathy. Definitive diagnosis of renal artery stenosis is made based on renal 
angiography.  
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3.2 Treatment 
Treatment of renal artery stenosis can be conservative (in cases in which graft perfusion is 
normal) or revascularization (surgery or percutaneous transluminal angioplasty [PTA]) can 
be performed. If stenosis is ≤60%, renal function is normal, and arterial hypertension is 
manageable with medical therapy, patients can be followed-up with Doppler US. In cases in 
which medical therapy is inadequate PTA (with or without stenting) is the treatment of 
choice (Figure 5). In cases with stenosis of the hilar region or distal renal bed, PTA is the 
preferred treatment option. Success rate of PTA/stenting was 60%-94%, the complication 
rate was 0.8%-3%, and 1 year post procedure 85% of stents remained unoccluded.24,25 
Permanent treatment of renal artery stenosis is surgery. PTA is not the treatment of choice in 
patients with renal artery stenosis due to arterial kinks or atherosclerotic diseases; in such 
patients surgical intervention should be performed. Surgery involves removal of the stenotic 
segment and re-anastomosis to the external iliac artery or anastomosis to the internal iliac 
artery using the saphenous vein. In cases of post-anastomotic stenosis the bypass grafting 
technique is used via autogenous graft. The surgical success rate varies between 63% and 
92%,26 and in 10%-12% of patients restenosis occurs within the first 8-9 months following 
surgery.27  
  
                                       (a)                                                                               (b) 
Fig. 5. a. Conventional angiography shows stenosis of the renal artery in a kidney transplant 
patient (arrow) b. Post-PTA conventional angiography shows successful stent implantation 
at the renal artery stenotic segment (arrow). 
4. Summary 
Renal transplantation is the treatment of choice for end-stage renal disease. Despite medical 
and surgical advances, vascular complications after kidney transplantation remain an 
important clinical problem that may increase morbidity, hospitalization and costs. Vascular 
complications in renal transplantation are not uncommon and may often lead to allograft 
loss. The most common vascular complications are renal artery stenosis, renal artery 
thrombosis and renal vein thrombosis. Transplant renal artery and vein thrombosis have an 
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early onset and a dramatic clinical manifestation and usually lead to allograft loss. These 
complications may compromise graft function and cause significant morbidity. Therefore, 
knowledge of the incidence, clinical manifestations and management of vascular 
complications is necessary for all kidney transplant surgeons. 
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